Table 3 Univariate analysis and multivariate analysis of the epigenetic signature
From: Epigenetic signature predicts overall survival clear cell renal cell carcinoma
Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
MS scores | 3.87 | (3.02–4.97) | < 0.001 | 3.09 | (2.35–4.08) | < 0.001 |
Age | 1.5 | (1.02–2.21) | 0.038 | 1.22 | (0.83–1.8) | 0.316 |
Gender | 1.06 | (0.71–1.59) | 0.772 | |||
Neoadjuvant treatment | 2.49 | (0.91–6.78) | 0.075 | |||
Lymph node count | 1 | (0.95–1.06) | 0.858 | |||
Histologic grade | 3.35 | (2.07–5.41) | < 0.001 | 1.26 | (0.75–2.13) | 0.378 |
Pathologic stage | 4.49 | (2.92–6.89) | < 0.001 | 2.42 | (1.52–3.86) | < 0.001 |